Versor Investments LP purchased a new stake in shares of Select Medical Holdings Corporation (NYSE:SEM – Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 11,300 shares of the health services provider’s stock, valued at approximately $189,000.
Several other large investors have also recently bought and sold shares of the business. Vista Finance LLC raised its position in Select Medical by 7.0% during the first quarter. Vista Finance LLC now owns 10,969 shares of the health services provider’s stock valued at $183,000 after buying an additional 716 shares during the period. Net Worth Advisory Group increased its stake in Select Medical by 6.4% in the 1st quarter. Net Worth Advisory Group now owns 14,045 shares of the health services provider’s stock valued at $235,000 after buying an additional 846 shares during the period. Caitong International Asset Management Co. Ltd increased its stake in Select Medical by 61.6% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,703 shares of the health services provider’s stock valued at $45,000 after buying an additional 1,030 shares during the period. M&T Bank Corp increased its stake in Select Medical by 5.8% in the 1st quarter. M&T Bank Corp now owns 36,629 shares of the health services provider’s stock valued at $612,000 after buying an additional 1,996 shares during the period. Finally, Lazard Asset Management LLC increased its stake in Select Medical by 47.8% in the 4th quarter. Lazard Asset Management LLC now owns 6,974 shares of the health services provider’s stock valued at $130,000 after buying an additional 2,255 shares during the period. 89.48% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several brokerages have weighed in on SEM. UBS Group reaffirmed a “neutral” rating and issued a $14.00 target price (down from $15.00) on shares of Select Medical in a research report on Monday, August 4th. Royal Bank Of Canada cut their price target on Select Medical from $23.00 to $19.00 and set an “outperform” rating for the company in a research note on Wednesday, May 7th. Three analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $20.25.
Select Medical Stock Up 3.2%
SEM opened at $13.4050 on Friday. The company has a market capitalization of $1.66 billion, a PE ratio of 12.65, a price-to-earnings-growth ratio of 0.69 and a beta of 1.25. The business has a 50-day moving average of $14.04 and a 200-day moving average of $15.74. Select Medical Holdings Corporation has a fifty-two week low of $11.65 and a fifty-two week high of $40.98. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.15 and a quick ratio of 1.15.
Select Medical (NYSE:SEM – Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The health services provider reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.04. The company had revenue of $1.34 billion during the quarter, compared to the consensus estimate of $1.35 billion. Select Medical had a return on equity of 8.87% and a net margin of 2.37%.The firm’s revenue was up 4.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.60 EPS. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS. Equities research analysts forecast that Select Medical Holdings Corporation will post 1.17 EPS for the current fiscal year.
Select Medical Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Thursday, August 28th. Stockholders of record on Wednesday, August 13th will be paid a dividend of $0.0625 per share. This represents a $0.25 annualized dividend and a dividend yield of 1.9%. The ex-dividend date is Wednesday, August 13th. Select Medical’s dividend payout ratio is 23.58%.
Select Medical announced that its board has initiated a stock repurchase program on Thursday, May 1st that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the health services provider to buy up to 42.6% of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s board believes its stock is undervalued.
Select Medical Profile
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Further Reading
- Five stocks we like better than Select Medical
- What Does Downgrade Mean in Investing?
- Royal Caribbean Earnings Beat Fuels Strong 2025 Outlook
- Insider Buying Explained: What Investors Need to Know
- Alphabet’s Breakout Potential: From Laggard to AI Leader
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- TJX Stock Price Hits Fresh High, Signals More Highs to Follow
Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings Corporation (NYSE:SEM – Free Report).
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.